S. Brodeur

588 Phase Ib study of the p38 inhibitor ARRY-614 with nivolumab, ipilimumab or nivolumab+ipilimumab in advanced solid tumors

D. Davar, Amy Rose, Y. Najjar, 2022, Regular and Young Investigator Award Abstracts.